GE HealthCare's Revolution™ Vibe CT System Receives FDA Clearance

GE HealthCare has received 510(k) clearance from the US Food and Drug Administration for its Revolution™ Vibe CT system. 

This new imaging platform is designed to improve coronary CT angiography (CCTA) using high-speed scanning and integrated AI tools. 

Cardiovascular disease remains the leading cause of death worldwide and demand for cardiac CT continues to rise. Revolution Vibe has been developed to help clinicians identify heart blockages quickly and non-invasively, while also improving patient comfort and workflow efficiency.

The system uses Unlimited One-Beat Cardiac imaging to produce high-quality full-heart scans at low dose, even in challenging cases such as arrhythmias, heavily calcified arteries, stents or bypasses. 

Advanced features including ECG-less Cardiac, TrueFidelity™ DL, SnapShot Freeze 2 and Effortless Cardiac Workflow further improve image quality, shorten scan times and simplify patient preparation.

Clinical evaluations have shown that Revolution Vibe can halve exam times, save up to five minutes in preparation per scan and double CCTA capacity. Automated protocols, streamlined positioning and reduced reliance on beta blockers and ECG leads support this efficiency.

Beyond heart imaging, Revolution Vibe also supports a wide range of general imaging needs. Its energy-efficient design, subscription model, fleet management tools and comprehensive training package are designed to help healthcare providers expand services and control lifecycle costs.